AIM ImmunoTech Inc
General ticker "AIM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $12.2M
AIM ImmunoTech Inc does not follow the US Stock Market performance with the rate: -36.4%.
Estimated limits based on current volatility of 5.5%: low 0.19$, high 0.21$
Factors to consider:
- Earnings expected soon, date: 2025-01-03 bmo
- Current price 27.9% below estimated low
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [0.25$, 0.70$]
- 2023-12-31 to 2024-12-30 estimated range: [0.26$, 0.69$]
Financial Metrics affecting the AIM estimates:
- Negative: Non-GAAP EPS, $ of -0.40 <= 0.10
- Negative: Operating profit margin, % of -99.30 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -47.14 <= 2.35
- Negative: Industry operating profit margin (median), % of -98.17 <= 2.14
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share, $ of 0 <= 0
Short-term AIM quotes
Long-term AIM plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.14MM | $0.14MM | $0.20MM |
Operating Expenses | $18.97MM | $20.06MM | $32.12MM |
Operating Income | $-18.84MM | $-19.92MM | $-31.92MM |
Non-Operating Income | $-0.29MM | $0.48MM | $2.95MM |
Interest Expense | $0.07MM | $0.00MM | $0.00MM |
R&D Expense | $7.67MM | $6.99MM | $10.94MM |
Income(Loss) | $-19.13MM | $-19.45MM | $-28.96MM |
Taxes | $2.39MM | $1.64MM | $0.00MM |
Profit(Loss) | $-21.51MM | $-21.09MM | $-28.96MM |
Stockholders Equity | $56.88MM | $38.47MM | $10.23MM |
Inventory | $0.00MM | $0.00MM | $0.30MM |
Assets | $57.70MM | $40.49MM | $19.38MM |
Operating Cash Flow | $-13.96MM | $-16.11MM | $-21.27MM |
Capital expenditure | $0.63MM | $0.27MM | $0.58MM |
Investing Cash Flow | $-0.63MM | $10.99MM | $-0.83MM |
Financing Cash Flow | $8.19MM | $0.08MM | $0.48MM |
Earnings Per Share* | $-0.45 | $-0.44 | $-0.60 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.